Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Ernexa Therapeutics (ERNA) reported Depreciation & Amortization (CF) of $9,000 for Q2 2026, down 47.1% from $17,000 a year earlier but up 12.5% from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ernexa Therapeutics' Depreciation & Amortization (CF) came in at $47,000, down 48.4% year-over-year; for FY2025, it came in at $65,000, down 53.2% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of -7.9% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $139,000 in FY2024 (+65.5%), $84,000 in FY2023 (-47.8%), $161,000 in FY2022 (+37.6%) and $117,000 in FY2021 (+19.4%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $8,000 in Q1 2026 and a high of $68,000 in Q2 2022.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last seven quarters, with an average decline of 29.0% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2024 (growth of 109.5%); the low point was Q2 2023 (a decline of 69.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $8,000 (Q1 2026), $13,000 (Q4 2025) and $17,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn - 9,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 8,000.00
Dec 31, 2025 13,000.00
Sep 30, 2025 17,000.00
Jun 30, 2025 17,000.00
Mar 31, 2025 18,000.00
Dec 31, 2024 19,000.00
Sep 30, 2024 37,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 39,000.00
Dec 31, 2023 22,000.00
Sep 30, 2023 20,000.00
Jun 30, 2023 21,000.00
Mar 31, 2023 21,000.00
Dec 31, 2022 17,000.00
Sep 30, 2022 40,000.00
Jun 30, 2022 68,000.00
Mar 31, 2022 36,000.00
Dec 31, 2021 24,000.00
Sep 30, 2021 30,000.00
API Access

Ernexa Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ERNA&period=max&api_key=YOUR_API_KEY